Skip to main content
. 2022 Feb 11;27(4):1216. doi: 10.3390/molecules27041216

Figure 4.

Figure 4

Compounds 1 and 2 have the same pharmacophoric features of the co-crystallized ligand of SARS CoV-2 PLP(TTT).